ARGENTIERO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.509
AS - Asia 1.034
EU - Europa 886
SA - Sud America 210
AF - Africa 54
OC - Oceania 1
Totale 4.694
Nazione #
US - Stati Uniti d'America 2.465
SG - Singapore 426
IT - Italia 303
CN - Cina 209
BR - Brasile 169
HK - Hong Kong 138
SE - Svezia 124
RU - Federazione Russa 116
DE - Germania 106
VN - Vietnam 74
FR - Francia 65
GB - Regno Unito 56
FI - Finlandia 45
BD - Bangladesh 44
IN - India 38
CA - Canada 25
ID - Indonesia 23
CI - Costa d'Avorio 16
ZA - Sudafrica 14
PL - Polonia 13
CZ - Repubblica Ceca 12
JP - Giappone 12
AR - Argentina 11
CO - Colombia 10
ES - Italia 10
TR - Turchia 10
IQ - Iraq 8
MX - Messico 7
PK - Pakistan 7
AT - Austria 6
UZ - Uzbekistan 6
BE - Belgio 5
EC - Ecuador 5
JO - Giordania 5
KE - Kenya 5
MA - Marocco 5
NL - Olanda 5
CL - Cile 4
LB - Libano 4
MY - Malesia 4
AL - Albania 3
BO - Bolivia 3
ET - Etiopia 3
IE - Irlanda 3
PH - Filippine 3
SA - Arabia Saudita 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
EG - Egitto 2
GE - Georgia 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KR - Corea 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
UA - Ucraina 1
Totale 4.694
Città #
Ashburn 328
Singapore 255
Fairfield 227
Chandler 223
Hong Kong 135
San Jose 132
Milan 121
Houston 117
Woodbridge 112
Seattle 110
Nyköping 102
Cambridge 89
Wilmington 77
Dallas 75
Beijing 74
Los Angeles 64
New York 63
Rome 50
Ann Arbor 38
Dearborn 38
Munich 33
Lauterbourg 31
Chicago 28
Lawrence 27
Council Bluffs 26
Helsinki 26
Roxbury 25
Brooklyn 24
Santa Clara 21
Jakarta 20
Buffalo 19
Des Moines 19
Columbus 18
Nanjing 18
Boardman 17
Abidjan 16
Frankfurt am Main 16
Ho Chi Minh City 16
Turku 16
Bari 15
Moscow 15
Dong Ket 14
Inglewood 14
Marseille 13
São Paulo 13
Figino 12
Montreal 12
Salt Lake City 12
Falkenstein 11
Johannesburg 11
Rio de Janeiro 11
San Diego 11
The Dalles 11
Turin 11
Chennai 10
Denver 10
Hanoi 10
London 10
Tokyo 10
Brno 9
Paris 9
Phoenix 9
Poplar 9
Warsaw 9
Orem 8
Guangzhou 7
Hefei 7
Naples 7
Stockholm 7
Belo Horizonte 6
Shanghai 6
Tampa 6
Brussels 5
Campinas 5
Düsseldorf 5
Jinan 5
Las Vegas 5
Princeton 5
Pune 5
Shenyang 5
Amman 4
Atlanta 4
Augusta 4
Elk Grove Village 4
Jacksonville 4
Lahore 4
Nanchang 4
Ottawa 4
Piscataway 4
Salvador 4
Tashkent 4
Washington 4
Beirut 3
Blumenau 3
Bologna 3
Boston 3
Dublin 3
Edinburgh 3
Grafing 3
Hebei 3
Totale 3.293
Nome #
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma 255
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 246
Angiogenesis in adenosquamous cancer of pancreas 226
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications 191
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 191
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 173
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 173
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 162
[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.] 157
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 146
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 139
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 138
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 137
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 136
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 136
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 135
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: Training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) 134
Actors on the scene: Immune cells in the myeloma niche 133
Molecular characterization of a long-term survivor double metastatic non-small cell lung cancer and pancreatic ductal adenocarcinoma treated with gefitinib in combination with gemcitabine plus nab-paclitaxel and mFOLFOX6 as first and second line therapy 131
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 125
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 123
The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer 110
Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets 109
The Italian Rare Pancreatic Exocrine Cancer Initiative 106
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 105
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 104
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 100
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 97
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 96
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 92
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 90
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 88
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 88
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 87
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 67
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 49
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead 48
Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma 29
Totale 4.852
Categoria #
all - tutte 20.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022228 10 14 9 5 11 19 6 13 21 12 37 71
2022/2023469 51 80 41 45 34 49 9 63 71 3 21 2
2023/2024229 13 29 11 24 18 71 3 12 2 4 2 40
2024/2025874 39 10 41 32 33 69 88 81 39 51 193 198
2025/20261.921 267 81 139 176 231 82 181 45 201 168 61 289
2026/202736 36 0 0 0 0 0 0 0 0 0 0 0
Totale 4.852